Cite
APA Citation
Kumar, S., Moreau, P., Hari, P., Mateos, M., Ludwig, H., Shustik, C., Masszi, T., Spencer, A., Hájek, R., Romeril, K., Avivi, I., Liberati, A. M., Minnema, M. C., Einsele, H., Lonial, S., Berg, D., Lin, J., Gupta, N., Esseltine, D., & Richardson, P. G. (2017). management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. British journal of haematology, 178, 571–582. http://access.bl.uk/ark:/81055/vdc_100047732304.0x000058